Ramaswamy’s latest startup, Ambros Therapeutics, launched Tuesday with plans to develop a treatment for a rare form of the chronic pain condition Complex Regional Pain Syndrome. Ambros already has a drug candidate in hand — The company has licensed neridronate from the Italian pharmaceutical company Abiogen Pharma S.p.A.
